Rimexolone is primarily used in ophthalmology as a corticosteroid to treat inflammation and pain in the eye. It is commonly prescribed for conditions such as postoperative inflammation following ocular surgery, uveitis, and other inflammatory eye disorders. The medication works by reducing the release of substances in the body that cause inflammation, thereby alleviating swelling, redness, and discomfort. It is typically administered as an ophthalmic suspension, ensuring targeted delivery to the affected area. Rimexolone is valued for its effectiveness in managing inflammation with a lower risk of increasing intraocular pressure compared to some other corticosteroids, making it a safer option for certain patients. Regular monitoring by a healthcare professional is recommended to ensure optimal results and minimize potential side effects.